Skip to main content
Category

News Archive

Notification Center

Emergent BioSolutions can make 1 billion Covid vaccine doses annually

By News Archive

Notification Center

As the U.S. makes headway in its coronavirus vaccination campaign, Emergent BioSolutions CEO Bob Kramer appeared on CNBC Wednesday to explain his company’s role in manufacturing doses.

The Gaithersburg, Maryland-based contractor last year landed a multi-year deal to be the domestic producer of the Covid-19 vaccine from Johnson & Johnson, whose single-dose shot was cleared for use in the U.S. over the weekend. It also has a multi-year contract production contract for a vaccine developed by a British-Swedish biopharmaceutical company, AstraZeneca.

Image: https://www.cnbc.com/ – From Video

Read More
Qiagen Logo

QIAGEN Launches QIAsphere Cloud-Based Connectivity Solution to Enhance QIAstat-Dx Capabilities in Digital Diagnostics | Business Wire

By News Archive

Qiagen Logo

HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)–QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has launched its QIAsphere cloud-based platform that will allow labs and QIAstat-Dx users to monitor tests and instrument status remotely 24 hours a day, 7 days a week.

QIAsphere sets new standards for syndromic testing digital health, providing users with remote visibility of their testing routine. It can monitor a nearly unlimited number of instruments, providing visibility of testing routine across different hospitals or satellite labs. The continuous connectivity to QIAGEN service reduces systems downtime and enabling fast and accurate syndromic testing. Digital diagnostics and remote analytics will be crucial to bring syndromic testing closer to patients in the coming years.

Read More
CN Master RGB HiRes Lg

Children’s National Hospital, Johnson & Johnson, Virginia Tech launch health innovation campus

By News Archive

CN Master RGB HiRes Lg

Washington, D.C.-based Children’s National Hospital, Virginia Tech and Johnson & Johnson Innovation have partnered to launch a new healthcare technology and research innovation campus, according to a March 1 news release.

The Children’s National Research & Innovation Campus will feature research into new pediatric medical treatments and technologies as well as a life sciences incubator for about 50 startups across the pharmaceutical, medical device, consumer and health tech sectors.

 

Read More
NewImage

Emergent Biosolutions Seeks New Talent to Support Global COVID-19 Vaccination Push, Expanding Project Portfolio · BioBuzz

By News Archive

NewImage

SARS-CoV-2 vaccinations are accelerating across the U.S. with approximately 66 million first doses having been administered as of February 25th, representing 13.6% of the country, according to NPR. The vaccination effort received another boost with the Food and Drug Administration’s recent Emergency Use Authorization (EUA) of Johnson & Johnson’s (J&J) single-dose vaccine. 

Image: https://biobuzz.io

Read More
Montgomery County Updates Inaugural Bio Boot Camp Classes Graduate as Part of Innovative County Workforce Initiative That Will Help Fill Jobs in Life Sciences Sector

Montgomery County Updates: Inaugural ‘Bio Boot Camp’ Classes Graduate as Part of Innovative County Workforce Initiative That Will Help Fill Jobs in Life Sciences Sector

By News Archive

Montgomery County Updates Inaugural Bio Boot Camp Classes Graduate as Part of Innovative County Workforce Initiative That Will Help Fill Jobs in Life Sciences Sector

Montgomery College and the Universities at Shady Grove (USG), in conjunction with the University of Maryland, Baltimore County (UMBC), have completed two intensive pilot training programs designed to create a skilled talent pipeline to support the life sciences sector in Montgomery County. The four-week “Bio Boot Camp” program—a public-private effort announced in November 2020—was created to help kickstart recovery from the COVID-19 health crisis.

Image: https://montgomerycomd.blogspot.com

Read More

Power Moves: Biotech entrepreneurs donate $5M to create the University of Maryland law school’s Chacón Center for Immigrant Justice – Technical.ly Baltimore

By News Archive

Marco and Debbie Chacón founded Paragon Bioservices.

(Photo courtesy of University of Maryland School of Law)

The entrepreneurs behind an exited Baltimore biotech company are creating a new center for immigration law in the city.

A $5 million gift from Marco and Debbie Chacón to the University of Maryland Francis King Carey School of Law will help to establish the Baltimore-based school’s new Chacón Center for Immigrant Justice.

The couple founded Paragon Bioservices, the contract manufacturing and development company that was acquired by Catalent in 2019 for $1.2 billion. Marco Chacón served as CEO and Debbie Chacón served as VP when the company moved to the University of Maryland BioPark in 2009. Now known as Paragon Gene Therapy, it still has a base at the BioPark, and Marco Chacón founded Irazú Bio, which is also based in the BioPark.

Image: Marco and Debbie Chacón founded Paragon Bioservices. (Photo courtesy of University of Maryland School of Law)

Read More
NewImage

Quality, Speed & Equity: Delivering COVID-19 Vaccines to the World

By News Archive

NewImage

All eyes are on the global rollout of COVID-19 vaccines. Achieving the broad uptake needed to reach population immunity and curb the virus’s spread will require an unprecedented effort among health workers, scientists and stakeholders at every step of the supply chain.

During this 90 min event, experts from organizations central to vaccine development and delivery, regulatory oversight and quality assurance will discuss over the course of two high-level panels what’s needed for the global COVID-19 vaccination campaign, how to build public trust in the quality and effectiveness of vaccines, and how these investments can build better systems for the future.

 

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.